For the Inventor, By the Inventor

Enter assignee name

Geneva, Switzerland

Addex Pharma, S.a.

USPTO Granted Patents = 37

% Expired Patents = 67.6

CIPO Patents = 9

EPO Patents = 27

Forward Citations = 183

Loading Chart...

Loading Chart...

43 inventors (with patents filed for the assignee):

Andrés Avelino Trabanco-Suárez (21 out of 53 patents)

Jose Maria Cid-Nunez (20 out of 21 patents)

Gregor James MacDonald (17 out of 56 patents)

4. Guillaume Albert Jacques Duvey (10 out of 11 patents)

5. Robert Johannes Lutjens (7 out of 8 patents)

6. Gary John Tresadern (5 out of 19 patents)

7. Juan Antonio Vega Ramiro (5 out of 10 patents)

8. Christelle Boléa (5 out of 5 patents)

9. Anne-Sophie Bessis (5 out of 6 patents)

10. Mark Epping-Jordan (5 out of 5 patents)

11. Jean-Philippe Rocher (5 out of 6 patents)

12. Terry Patrick Finn (4 out of 9 patents)

13. Daniel Oehlrich (4 out of 16 patents)

14. Christelle Bolea (4 out of 6 patents)

15. Beatrice Bonnet (4 out of 4 patents)

Core Competencies:

Allosteric Modulators

Metabotropic Glutamate Receptors

Pyridine Derivatives

Neurological Disorders

Psychiatric Disorders

MGLU5 Receptor

Tetrahydropyrazolo

Thiazoles Derivatives

Indole Derivatives

Cyano-Pyridone

Heteroaromatic Derivatives

Pyrazole Derivatives

37 patents: Sort by Forward Citations

1. 10071095 - 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurological and psychiatric disorders (2018-09-11),

2. 9938270 - Mono-phosphate salt of 6-fluoro-2-[4-(pyridin-2-yl)but-3-yn-1-yl]imidazo[1,2A]pyridine (dipraglurant) and polymorphs thereof as negative allosteric modulator of MGLU5 receptor (2018-04-10),

3. 9765091 - Tetrahydropyrazolo [3,4-b] azepine derivatives and their use as allosteric modulators of metabotropic glutamate receptors (2017-09-19),

4. 9737533 - 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders (2017-08-22),

5. 9266834 - 1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors (2016-02-23),

6. 9226930 - 1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders (2016-01-05),

7. 9132122 - [object Object] (2015-09-15),

8. 9114138 - [object Object] (2015-08-25),

9. 9085577 - 7-aryl-1,2,4-triazolo[4,3-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors (2015-07-21),

10. 9073907 - Thiazoles derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors (2015-07-07),

11. 9067891 - 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mGluR2-receptors (2015-06-30),

12. 8946205 - 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors (2015-02-03),

13. 8937060 - 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders (2015-01-20),

14. 8906939 - 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives (2014-12-09),

15. 8883826 - Alkynyl derivatives as modulators of metabotropic glutamate receptors (2014-11-11),

Company Overview

Addex Pharma, based in Geneva, Switzerland, specializes in the development of innovative therapies for neurological disorders. The company focuses on allosteric modulation, a cutting-edge approach that aims to enhance or inhibit the activity of specific receptors in the brain. With a strong emphasis on research and development, Addex is dedicated to advancing treatments for conditions such as Parkinson's disease and other central nervous system disorders, leveraging its expertise in pharmacology and drug discovery.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

37 Patents

#13 in Geneva

#407 in Switzerland

#18,299 in the World

Geneva, Switzerland

Addex Pharma, S.a.

Forward Citations = 183

43 inventors:

Andrés Avelino Trabanco-Suárez (21 out of 53 patents)

Jose Maria Cid-Nunez (20 out of 21 patents)

Gregor James MacDonald (17 out of 56 patents)

4. Guillaume Albert Jacques Duvey (10 out of 11 patents)

5. Robert Johannes Lutjens (7 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Addex Pharma, S.a.. Retrieved from https://idiyas.com/company/addex-pharma-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…